GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.
about
Liver fibrosis markers of nonalcoholic steatohepatitis.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Alterations of serum protein N-glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven.Cell surface-specific N-glycan profiling in breast cancerDecreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity.N-glycans in liver-secreted and immunoglogulin-derived protein fractions.Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseNon-alcoholic fatty liver disease proteomicsStructural glycomic analyses at high sensitivity: a decade of progressQuantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.Aberrant glycosylation associated with enzymes as cancer biomarkers.Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.N-Glycan profiling of dried blood spotsAnalysis of glycans derived from glycoconjugates by capillary electrophoresis-mass spectrometry.Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.Analytical glycobiology at high sensitivity: current approaches and directionsExtracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Glycoprotein disease markers and single protein-omicsQuantitative glycomics strategiesSite-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinomaMutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction.Increased sialylation of site specific O-glycoforms of hemopexin in liver disease.Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants.Glycome profiling using modern glycomics technology: technical aspects and applications.High-sensitivity analytical approaches for the structural characterization of glycoproteins.Relative versus absolute quantitation in disease glycomics.Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor.Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach.Glycosylation profiling of dog serum reveals differences compared to human serum
P2860
Q30407625-40B2A58E-E0BB-46E8-ABD9-E3C22A3C5CBBQ30432576-C4BAF820-7B9A-4DCF-90A8-9F926FDE158EQ30997802-B8B370D0-BA05-473B-9E72-6F477CAC09D9Q31137153-070C791C-D7A2-427F-9343-BD796F57D078Q33689369-C2EA6A4C-2950-402E-BC58-D0D1EBC3FF12Q34156760-26EBDE95-AC2C-4F53-B948-73A6411A48A6Q34417027-C2932D74-0927-4CB3-838A-5CC723C9666EQ34464343-9DB3188E-418D-4CFD-8B1E-F99D7C418BF2Q34578790-8C0F2132-80F1-4F83-8EA8-43594D5CEAE1Q34656853-D174472E-7543-4C35-8E3E-B6E508C03F7CQ35085189-FF7C5FB4-2699-40D6-BA98-5204CAEEC82FQ35206309-72E61C75-193A-4F22-9A23-4EC5F1F59253Q35649524-7E4F39F6-5276-46DC-BBD1-B20AD5D0B68FQ35675417-72C8E1E6-1A32-410E-9644-75215E8827EEQ35988418-B8F5EE63-7E9B-46B8-A00C-0C729F92F32AQ36155480-AC9C66EE-7B1C-4DF5-BD27-48CA3131BE44Q36249639-DD590B81-EB7A-4D5C-AEE8-0A943BEB0F6FQ36651493-AC888446-E912-4600-879D-2179CF883B65Q36672445-47F49406-4817-4928-AE46-D939602414DAQ36742398-A41CF83C-8691-4F01-B4FA-A8851A02A4B2Q36742414-A58DAC05-E8ED-4A9A-B607-7456245D7923Q36832489-66EB5AB9-A5E2-4E79-921A-532E56EF1EF5Q37217021-13314AD7-6167-4567-9909-7C137B4F16BDQ37278723-AB36807D-1EA5-4822-A14C-638B3F4C7720Q37678208-FFE9794D-8FB2-4DEE-938C-E9BE97BEB2F6Q37686527-20F964E0-E11C-4738-9252-E0A17110B9AFQ37712517-A88DF8D0-B213-4DCC-9AC0-6F672D476B9DQ38356585-6CC9B846-8ECA-4EA6-867B-B83D1BFB90D7Q39373031-6A4D3356-0917-4C5B-A8DB-045C2D65F118Q40966087-0B70BE6E-8E58-49C1-8C98-C1BA86DE5B74Q42528372-4EBF89ED-A205-4D60-8987-E02732909B30Q43199850-F470D80E-5B04-40F9-B444-FD9AD09D7B5BQ43851747-5CC3D1AE-4464-4C04-94FF-895B787B94E0Q45072735-18ED9904-1193-4AC7-B615-7FD69D236B33Q47360925-C25BCE0C-FD41-4F6A-AB0C-DE609191619AQ57168457-55456D34-84F8-49AE-8033-58AAF8D48BAB
P2860
GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@en
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@nl
type
label
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@en
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@nl
prefLabel
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@en
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@nl
P2093
P2860
P1476
GlycoFibroTest is a highly per ...... based serum protein glycomics.
@en
P2093
Annelies Van Hecke
Dieter Vanderschaeghe
Erwin Sablon
Joris Delanghe
Philippe Halfon
Wouter Laroy
P2860
P304
P356
10.1074/MCP.M800470-MCP200
P577
2009-01-29T00:00:00Z